Fundraising Foxデ・ウエスタン・セラピテクス研究所
1 known investors
Find your way into デ・ウエスタン・セラピテクス研究所
Sign up to see every warm intro you have to デ・ウエスタン・セラピテクス研究所
- Paths you didn't know you had: your email and LinkedIn already hold routes to the デ・ウエスタン・セラピテクス研究所 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A Japanese biotech venture focused on drug discovery, developing novel pharmaceuticals with the goal of bringing innovative new drugs from Japan to the global market. It works from a proprietary compound library centered on protein kinase inhibitors built up through the founder's research activities.
Investors · 1
Frequently asked questions
- What does デ・ウエスタン・セラピテクス研究所 do?
- A Japanese biotech venture focused on drug discovery, developing novel pharmaceuticals with the goal of bringing innovative new drugs from Japan to the global market. It works from a proprietary compound library centered on protein kinase inhibitors built up through the founder's research activities.
- Who are デ・ウエスタン・セラピテクス研究所's investors?
- デ・ウエスタン・セラピテクス研究所's investors include Whiz Partners Inc..